Showing results (251-260 of 285) with videos related to

Sort By:
Pageof 29
World Journal of Hepatology|November 27, 2015
Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis CSatoshi Hiramine, Norihiro Furusyo, Eiichi Ogawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 4, 2005
Efficacy of prolonged treatment following combination with ribavirin and interferon for chronic hepatitis type C: A pilot studyHideyuki Nomura, Yoichiro Kashiwagi, Hisashi Nakashima, et al.
Comparative Hepatology|May 2, 2007
Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patientsMakoto Nakamuta, Kazuhiro Kotoh, Munechika Enjoji, et al.
Internal Medicine (Tokyo, Japan)|February 23, 2026
A Case of Tuberculous Pleurisy Highlighting the Need to Consider Primary Tuberculosis in Interferon-Gamma Release Assay-Negative PatientsSaki Takeda, Tatsuya Nagai, Taiki Kawai, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 19, 2020
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis BEiichi Ogawa, Hideyuki Nomura, Makoto Nakamuta, et al.
Journal of Gastroenterology|December 4, 2016
NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1bEiichi Ogawa, Norihiro Furusyo, Hideyuki Nomura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 18, 2005
Body surface area is an independent factor contributing to the effects of lamivudine treatmentMakoto Nakamuta, Kazuhiro Kotoh, Yuichi Tanabe, et al.
Antiviral Research|October 10, 2018
Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney diseaseEiichi Ogawa, Norihiro Furusyo, Koichi Azuma, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 21, 2015
Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis CHiroaki Ikezaki, Hideyuki Nomura, Norihiro Furusyo, et al.
World Journal of Gastroenterology|February 21, 2006
Long-term lamivudine treatment for chronic hepatitis B in Japanese patients: a project of Kyushu University Liver Disease StudyNorihiro Furusyo, Hiroaki Takeoka, Kazuhiro Toyoda, et al.
Pageof 29